Hedge Funds Are Buying Amicus Therapeutics, Inc. (FOLD)

Page 2 of 2

With the results exhibited by the aforementioned studies, retail investors must always monitor hedge fund and insider trading sentiment, and Amicus Therapeutics, Inc. (NASDAQ:FOLD) is an important part of this process.

Click here to learn why you should track hedge funds

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Cytokinetics, Inc. (NASDAQ:CYTK) 8 0 0
ArQule, Inc. (NASDAQ:ARQL) 11 0 0
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) 12 0 0
Pain Therapeutics, Inc. (NASDAQ:PTIE) 10 0 0
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) 9 2 2
Page 2 of 2